Paper31887811
Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index.
Tobari M and 1 other. Gut Liver, 2020. Cited by 48 papers, by iCite.
Cite this record
ConductScience Library. Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index. Papers, record 31887811. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31887811
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Non-alcoholic Fatty Liver Disease | Major topic |
| Body Mass Index | |
| Female | |
| Humans | |
| Japan | |
| Liver | |
| Male | |
| Obesity | |
| Prevalence | |
| Risk Factors |
Source PubMed
References102
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21145841 | Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. | J Hepatol | 2011 | https://conductscience.org/library/papers/21145841 | PubMed |
| 2 | 30058778 | Clinicopathological investigation of steatohepatitic hepatocellular carcinoma: A multicenter study using immunohistochemical analysis of adenoma-related markers. | Hepatol Res | 2018 | https://conductscience.org/library/papers/30058778 | PubMed |
| 3 | 18081233 | Prevalence of fatty liver disease and its risk factors in the population of South China. | World J Gastroenterol | 2007 | https://conductscience.org/library/papers/18081233 | PubMed |
| 4 | 27599824 | Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. | J Hepatol | 2017 | https://conductscience.org/library/papers/27599824 | PubMed |
| 5 | 2643548 | The effect of age upon liver volume and apparent liver blood flow in healthy man. | Hepatology | 1989 | https://conductscience.org/library/papers/2643548 | PubMed |
| 6 | 10833486 | Liver fibrosis in overweight patients. | Gastroenterology | 2000 | https://conductscience.org/library/papers/10833486 | PubMed |
| 7 | 28670712 | Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment. | J Gastroenterol Hepatol | 2018 | https://conductscience.org/library/papers/28670712 | PubMed |
| 8 | 30991959 | Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States. | BMC Gastroenterol | 2019 | https://conductscience.org/library/papers/30991959 | PubMed |
| 9 | 23994581 | Estrogen: a master regulator of bioenergetic systems in the brain and body. | Front Neuroendocrinol | 2014 | https://conductscience.org/library/papers/23994581 | PubMed |
| 10 | 14726171 | Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. | Lancet | 2004 | https://conductscience.org/library/papers/14726171 | PubMed |
| 11 | 25125077 | Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. | Hepatology | 2015 | https://conductscience.org/library/papers/25125077 | PubMed |
| 12 | 22328022 | Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. | J Gastroenterol | 2012 | https://conductscience.org/library/papers/22328022 | PubMed |
| 13 | 16522283 | Metabolic syndrome in the elderly. | Curr Diab Rep | 2006 | https://conductscience.org/library/papers/16522283 | PubMed |
| 14 | 16287793 | The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. | Ann Intern Med | 2005 | https://conductscience.org/library/papers/16287793 | PubMed |
| 15 | 31068503 | High sex hormone-binding globulin concentration is a risk factor for high fibrosis-4 index in middle-aged Japanese men. | Endocr J | 2019 | https://conductscience.org/library/papers/31068503 | PubMed |
| 16 | 19670076 | Final results of a long-term, clinical follow-up in fatty liver patients. | Scand J Gastroenterol | 2009 | https://conductscience.org/library/papers/19670076 | PubMed |
| 17 | 25003744 | Sex-specific prevalence of fatty liver disease and associated metabolic factors in Wuhan, south central China. | Eur J Gastroenterol Hepatol | 2014 | https://conductscience.org/library/papers/25003744 | PubMed |
| 18 | 17610504 | Influence of age and gender in Japanese patients with non-alcoholic steatohepatitis. | Hepatol Res | 2007 | https://conductscience.org/library/papers/17610504 | PubMed |
| 19 | 16817817 | Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. | Clin Endocrinol (Oxf) | 2006 | https://conductscience.org/library/papers/16817817 | PubMed |
| 20 | 17498218 | What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? | J Gastroenterol Hepatol | 2007 | https://conductscience.org/library/papers/17498218 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42399578 | Prevalence and associated factors of metabolic dysfunction-associated steatotic liver disease in Taiwan, 2001-2021. | Hepatol Int | 2026 | https://conductscience.org/library/papers/42399578 | PubMed |
| 42116409 | Identifying the association between hemoglobin levels and metabolic dysfunction-associated steatotic liver disease: An observational study and Mendelian randomization analysis. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/42116409 | PubMed |
| 41574293 | Determinants of abnormal liver-related biomarkers in adult COVID-19 patients. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/41574293 | PubMed |
| 41455979 | The importance of sex dimorphism in liver metabolism and progressive liver diseases. | Biol Sex Differ | 2025 | https://conductscience.org/library/papers/41455979 | PubMed |
| 41087942 | Association of cardiometabolic index with non-alcoholic fatty liver disease among Iranian adults of the amol cohort study. | BMC Gastroenterol | 2025 | https://conductscience.org/library/papers/41087942 | PubMed |
| 40336965 | The relationship between dietary sodium intake and all-cause mortality in patients with non-alcoholic fatty liver disease: a cohort study from NHANES 2003-2018. | Front Nutr | 2025 | https://conductscience.org/library/papers/40336965 | PubMed |
| 40299427 | MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women. | Biomedicines | 2025 | https://conductscience.org/library/papers/40299427 | PubMed |
| 40001266 | Risk factor analysis and predictive model construction of lean MAFLD: a cross-sectional study of a health check-up population in China. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/40001266 | PubMed |
| 39846638 | Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD. | Pathophysiology | 2025 | https://conductscience.org/library/papers/39846638 | PubMed |
| 39619223 | Clinical Characteristics, Risk Factors, and Predictors of Nonobese Fatty Liver Disease: A Cross-Sectional Study. | Diabetes Metab Syndr Obes | 2024 | https://conductscience.org/library/papers/39619223 | PubMed |
| 39599633 | Body Composition in Cases with Normal Alanine Aminotransferase Values in Medical Health Checkups. | Nutrients | 2024 | https://conductscience.org/library/papers/39599633 | PubMed |
| 39334354 | The Clínica Universidad de Navarra-Body Adiposity Estimator index is a reliable tool for screening metabolic dysfunction-associated steatotic liver disease: an analysis from a gender perspective. | Lipids Health Dis | 2024 | https://conductscience.org/library/papers/39334354 | PubMed |
| 39108890 | Analysis of machine learning based integration to identify the crosslink between inflammation and immune response in non-alcoholic fatty liver disease through bioinformatic analysis. | Heliyon | 2024 | https://conductscience.org/library/papers/39108890 | PubMed |
| 38577539 | Update in lean metabolic dysfunction-associated steatotic liver disease. | World J Hepatol | 2024 | https://conductscience.org/library/papers/38577539 | PubMed |
| 38162856 | HbA1c of 5.8% or higher as the most useful indicator for recommendation of ultrasonography to detect nonalcoholic fatty liver disease. | JGH Open | 2023 | https://conductscience.org/library/papers/38162856 | PubMed |
| 37901792 | Sex-specific relationship between non-alcoholic fatty liver disease and amyloid-β in cognitively unimpaired individuals. | Front Aging Neurosci | 2023 | https://conductscience.org/library/papers/37901792 | PubMed |
| 37607790 | Clinical characteristics in patients with non-alcoholic steatohepatitis in Japan: a case-control study using a 5-year large-scale claims database. | BMJ Open | 2023 | https://conductscience.org/library/papers/37607790 | PubMed |
| 37559192 | Malnutrition and inflammation status in nonobese patients with inflammatory bowel disease are associated with nonalcoholic fatty liver disease: a retrospective study. | Intest Res | 2023 | https://conductscience.org/library/papers/37559192 | PubMed |
| 37484966 | A non-linear relationship between triglyceride glucose waist circumference and nonalcoholic fatty liver disease in a Japanese population: a secondary analysis. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37484966 | PubMed |
| 37396181 | Uncoupling hepatic insulin resistance - hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37396181 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GH1 | 2688 | PubTator's text mining | https://conductscience.org/library/genes/2688 | NCBI Gene |
| IGF1 | 3479 | PubTator's text mining | https://conductscience.org/library/genes/3479 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| PNPLA3 | 80339 | PubTator's text mining | https://conductscience.org/library/genes/80339 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31887811
GET https://conductscience.org/api/papers/v1/31887811/references?page=2